GB0721333D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB0721333D0
GB0721333D0 GBGB0721333.3A GB0721333A GB0721333D0 GB 0721333 D0 GB0721333 D0 GB 0721333D0 GB 0721333 A GB0721333 A GB 0721333A GB 0721333 D0 GB0721333 D0 GB 0721333D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0721333.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Motac Neuroscience Ltd
Original Assignee
Motac Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Motac Neuroscience Ltd filed Critical Motac Neuroscience Ltd
Priority to GBGB0721333.3A priority Critical patent/GB0721333D0/en
Publication of GB0721333D0 publication Critical patent/GB0721333D0/en
Priority to PCT/GB2008/003643 priority patent/WO2009056811A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0721333.3A 2007-10-31 2007-10-31 Medicaments Ceased GB0721333D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0721333.3A GB0721333D0 (en) 2007-10-31 2007-10-31 Medicaments
PCT/GB2008/003643 WO2009056811A2 (fr) 2007-10-31 2008-10-28 Médicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0721333.3A GB0721333D0 (en) 2007-10-31 2007-10-31 Medicaments

Publications (1)

Publication Number Publication Date
GB0721333D0 true GB0721333D0 (en) 2007-12-12

Family

ID=38834565

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0721333.3A Ceased GB0721333D0 (en) 2007-10-31 2007-10-31 Medicaments

Country Status (2)

Country Link
GB (1) GB0721333D0 (fr)
WO (1) WO2009056811A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010025235A1 (fr) * 2008-08-29 2010-03-04 Regents Of The University Of Michigan Ligands sélectifs du récepteur dopaminergique 3 (d<sb>3</sb>) et procédés pour les utiliser
EP2446756B2 (fr) * 2010-10-29 2021-11-10 British American Tobacco (Investments) Limited Procédé et appareil permettant d'introduire des additifs dans des produits de tabac sans fumée

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3620813A1 (de) * 1986-06-21 1987-12-23 Boehringer Ingelheim Kg Neue tetrahydro-benzothiazole, ihre herstellung und verwendung
FR2731619A1 (fr) * 1995-03-14 1996-09-20 Logeais Labor Jacques Compositions pharmaceutiques contenant de la l-etrabamine, leurs utilisations et leurs procedes de preparation
EP0923542B1 (fr) * 1996-05-31 2003-08-20 PHARMACIA &amp; UPJOHN COMPANY Amines cycliques a substitution aryle utilisees comme ligands de la dopamine d3
US7365205B2 (en) * 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
EP1617856B1 (fr) * 2003-04-11 2014-01-15 Ipsen Pharma Analogues chimeres de la somatostatine-dopamine
ATE496036T1 (de) * 2004-03-19 2011-02-15 Dipharma Francis Srl Zwischenprodukte für die herstellung von pramipexol
CA2619217A1 (fr) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestauration avec du pramipexole r(+)
US20100009969A1 (en) * 2006-07-27 2010-01-14 Ucb Pharma, S.A. Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands
CL2007003874A1 (es) * 2007-01-03 2008-05-16 Boehringer Ingelheim Int Compuestos derivados de benzamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiovasculares, hipertension, aterosclerosis, reestenosis, ictus, insuficiencia cardiaca, lesion isquemica, hipertensio
WO2008086353A1 (fr) * 2007-01-08 2008-07-17 Zurawski Vincent R Jr Dérivés contenant du propargyle de tétrahydro-benzthiazoles et procédés de fabrication et d'utilisation de ceux-ci
GB0707704D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2009056811A3 (fr) 2009-10-15
WO2009056811A2 (fr) 2009-05-07

Similar Documents

Publication Publication Date Title
ZA200905959B (en) Inhaler
EP2212908A4 (fr) Transistor à effet de champ à jonction à ailette
DE602008005470D1 (en) Imidazopyridinone
ZA200909172B (en) Inhaler
GB0720730D0 (en) Soother
AP2010005314A0 (en) Nanodispersian
ZA201001435B (en) Inhaler
GB0721332D0 (en) Medicaments
AU321241S (en) Inhaler
GB0613031D0 (en) Medicaments
GB0721333D0 (en) Medicaments
GB0717450D0 (en) Medicament
GB0717882D0 (en) Novel pharmaceutical
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3702P (en) DarwinGold Dianella ensifolia
AU3646P (en) TAS300 Dianella tasmanica
AU3642P (en) TAS100 Dianella tasmanica
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3606P (en) Jaywick xTriticosecale
AU3595P (en) Goldust Strobilanthes anisophyllus
GB0706441D0 (en) Concept nine
AU315171S (en) Inhaler
GB0708653D0 (en) Inhaler
AU316590S (en) Multi-sander

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)